Fabrice Barlési - Researcher Profile

Publications

2 shown

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Mark A. Socinski , Robert M. Jotte , Federico Cappuzzo +17 more

The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NS...

2018 New England Journal of Medicine 3592 citations

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei , L. Paz-Ares , Leora Horn +25 more

Among patients with advanced nonsquamous NSCLC that had progressed during or after platinum-based chemotherapy, overall survival was longer with nivolumab than with docetaxel. (...

2015 New England Journal of Medicine 9225 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 12,817
Institution: Aix-Marseille Université

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5793-3539

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.